IP Library Granted Patent US 8,883,474
Granted Patent B2
US 8,883,474 · App. 14/136,152 · Granted Nov 11, 2014

Solubilized phospholipids for stabilizing nucleic acid polymerases

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,883,474
App. No.
14/136,152
Granted
Nov 11, 2014
Kind
B2
Abstract

Compositions and methods are provided that relate to solubilized phospholipids and their use in stabilizing nucleic acid polymerases. For example, a phospholipid with a tail containing at least 8 carbons can be solubilized in the presence of an amphipathic molecule.

Claims (7)

1. A method comprising:

providing a thermostable polymerase in a buffer and a solubilized long-chain phospholipid, wherein the solubilized phospholipid has at least 8 to 30 carbons; and

stabilizing the thermostable polymerase.

2. A method according to claim 1 , wherein the solubilized long-chain phospholipid is solubilized by adding an amphipathic molecule.

3. A method according to claim 2 , wherein the solubulizer is a lipid having a side chain of no more than 8 carbons.

4. A method according to claim 1 , further comprising:

enhancing the activity of the polymerase in the presence of the solubilized phospholipid as can be measured in a replication assay by incorporation of deoxynucleoside triphosphate.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 14, 2023
From: JOHNSON, DONALD; EVANS, THOMAS C, JR.
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 064575/0427 →